Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Wolff (Borstel, Germany), N. El-Merhie (Borstel, Germany), S. Reuter (Borstel, Germany), T. Goldmann (Borstel, Germany), A. Yildirim (Munich, Germany), H. Fehrenbach (Borstel, Germany), S. Krauss-Etschmann (Borstel, Germany). LSC - 2019 - Relevant murine model to study the development of COPD pathogenesis in smokers with viral infections. 2408

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Use of differentiated primary human airway epithelial models to study SARS-CoV-2 infection biology and pathogenesis Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 Colonisation in stable patients with COPD: results of an Italian epidemiological study (PRIME study) Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection Source: Annual Congress 2013 –COPD and infections Year: 2013 Bacterial infection in hospitalized patients of acute exacerbation of COPD and their relation to lung function: A prospective study Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients Year: 2016 Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD Source: Eur Respir Rev, 28 (151) 180063; 10.1183/16000617.0063-2018 Year: 2019 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 LSC - 2019 - The role of miR-155 in a mouse model of TDI-induced asthma Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 Can the influenza vaccine response be predicted in COPD patients by clinical parameters? Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 The effect of influenza virus infection on airway inflammation in a murine model of asthma Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Genetic determinants of oropharyngeal streptococci antimicrobial resistance in COPD patients and asthma sufferers Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Longitudinal profiling of viral infections in COPD patients and their implication to exacerbations Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 Definition and characterization of an inflammatory phenotype in patients with COPD - results from the COSYCONET study Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Tiotropium attenuates pulmonary inflammation in a novel mouse smoke RSV re-infection model Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections Year: 2014 The role of viral and bacterial infections on the development and exacerbations of asthma Source: Eur Respir Mon 2012; 56: 115-127 Year: 2012 Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 LATE-BREAKING ABSTRACT: Discovering new treatments for asthma and COPD. The use of the human viral challenge model with a newly manufactured and characterised GMP human rhinovirus Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016